PAK1 and neoplasm: Furthermore, the upregulation of PAK1 over four weeks was found to be involved in T-cell receptor signaling pathways (Fig. 4c), indicating that the increase of PAK1 level in PAK4KO tumour over time may contribute to their immune resistance.